<DOC>
	<DOCNO>NCT00432770</DOCNO>
	<brief_summary>The purpose study establish overall safety tolerability ARC1779 healthy volunteer , characterize pharmacokinetic pharmacodynamic profile respect parameter platelet function von Willebrand Factor activity .</brief_summary>
	<brief_title>Safety , Pharmacokinetics , Pharmacodynamics ARC1779 Healthy Volunteers</brief_title>
	<detailed_description>The purpose study establish overall safety tolerability ARC1779 healthy volunteer , characterize pharmacokinetic pharmacodynamic profile respect parameter platelet function von Willebrand Factor activity .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>≥ 18 ≤ 65 year age Weight ≤ 110 kg Negative qualitative urine drug/alcohol test Female volunteer must nonchildbearing potential Male volunteer must agree use medically acceptable contraceptive Volunteers must capable understand comply protocol must sign informed consent document Any clinically significant medical disorder ( e.g . diabetes , hypertension , etc . ) Tendency bleed easily History recent trauma surgery History gout renal stone Clinically significant abnormal lab parameter follow : PT INR &gt; 1.4 aPTT &gt; reference laboratory value Serum creatinine &gt; 1.3 mg/dL Platelet count ≤ 100,000/mm3 ALT/AST &gt; 2 time ULN WBC ≤ 3000 x 109/L Hemoglobin &lt; 11 g/dL Total bilirubin &gt; 1.2 mg/dL CBT &gt; 15 min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>